Petros Pharmaceuticals, Inc（PTPI）美股招股说明书 S-1 （2022-01-06首版）（英文版）（237页）.pdf

1、Table of ContentsAs Filed with the Securities and Exchange Commission on January 6,2022Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form S-1UNDERTHE SECURITIES ACT OF 1933PETROS PHARMACEUTICALS,INC.(Exact Name of Registrant as Specified in its Charter)Delawa

2、re283485-1410058(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)1185 Avenue of the Americas,Suite 249New York,New York 10036973-242-0005(Address,including zip code,and telephone number,including are

3、a code,of registrants principal executive offices)Fady BoctorPresident and Chief Commercial OfficerPetros Pharmaceuticals,Inc.1185 Avenue of the Americas,Suite 249New York,New York 10036973-242-0005(Name,address,including zip code,andtelephone number,including area code,of agent for service)Copies t

4、o:Rick A.Werner,Esq.Jayun Koo,Esq.Haynes and Boone,LLP30 Rockefeller Plaza,26th FloorNew York,New York 10112(212)659-7300Approximate date of commencement of proposed sale to the public:As soon as practicable after this registrationstatement is declared effective.If any of the securities being regist

5、ered on this Form are to be offered on a delayed or continuous basis pursuant toRule 415 under the Securities Act of 1933 check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following box and

6、 list the Securities Act registration statement number of the earlier effectiveregistration statement for the same offering.2025/9/12 09:23sec.gov/Archives/edgar/data/1815903/000110465922001924/tmb-20220106xs1.htmhttps:/www.sec.gov/Archives/edgar/data/1815903/000110465922001924/tmb-20220106xs1.htm1/